Documente Academic
Documente Profesional
Documente Cultură
com
Industry, 2008-2010
Description
z Selling point
The data of this report partly comes from such authorities as State Statistics Bureau,
Ministry of Health and industry associations, and our research center which has various
first-hand materials through field research and interview with specialists. The report has
analyzed China’s biopharmaceutical industry in terms of production and sales, import and
development trend.
Page 2 of 8
Market Report on China’s Biopharmaceutical Industry, 2008-2010
8
6.8
7
Unit in Billion USD
6
5
5
3.7
4
2.7 3
3
2
1
0
2003 2004 2005 2006 2007
Source:www.shcri.com
favorable factors as China’s rapid economic growth, people’s higher income, increasing
important role in national economy and draws more attention from investors.
With the improvement of health care system and people’s rising awareness of disease
treatment, more non-conservative treatment methods are used in clinical treatment, which
has promoted the development of blood products. Currently, blood products frequently
The demand of charged vaccine has increased dramatically with the rising consumption
power and health awareness of people so that charged vaccine market is expanding rapidly.
Charged vaccine as a supplement to free vaccine program has promoted the rapid growth
of domestic vaccine market, the external diagnostic reagent is becoming familiar with
biological drugs. Nowadays genetic drugs and antibody drugs are replacing the chemical
drugs which have many side effects to cure the cancer patients, and this will bring more
Page 3 of 8
www.shcri.com
The import and export volume of China’s biopharmaceutical products was 377 million
dollars in 2007, increased by 48% as compared with last year. The import volume reached
336 million dollars, increased by 51% as compared with 2006, and the export volume was
41 million dollars .The growth rate of export volume in 2007 had declined from the level of
58% in 2006 to 26% in 2007. Although the export of China’s biopharmaceutical industry
constantly kept a high growth rate, the volume is very small as compared with the import
volume. As mentioned above, the export volume was only 41 million dollars in 2007
whereas the import volume added up to 336 million USD. This sharp contrast indicated that
China’s biopharmaceutical products accounted for a very low market ratio in international
market.
Table of Contents
Table of Contents
Page 4 of 8
Market Report on China’s Biopharmaceutical Industry, 2008-2010
1.5 Analysis of prices and the balance between supply and demand
1.5.1 Forecast and analysis of the balance between supply and demand
3.2 Vaccine
Page 5 of 8
www.shcri.com
4.5 Shanghai
5.3.1 Profiles
5.3.3 Operations
Page 6 of 8
Market Report on China’s Biopharmaceutical Industry, 2008-2010
to 2010
Selected Charts
Chart The world’s top 20 biopharmaceutical corporations in 2007
Page 7 of 8
www.shcri.com
biopharmaceutical industry
Chart List of China’s blood products manufacturers passed GMP certification in 2007
Chart The major cases about annexation and technology transfer of the world vaccine
Chart Analysis of market scales of the global major gene drugs, 2004-2010
2004-2007
Companies mentioned
Page 8 of 8